8-K
Current Report
Cellectar Biosciences, Inc. Filed Acc 0001144204-17-030585
Executive or director change · Bylaws or fiscal year change · Shareholder vote results
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading v468188_8k.htm…